H

Hoth Therapeutics
D

HOTH

0.84800
USD
0.00
(0.22%)
Market Closed
Volume
1,222
EPS
-1
Div Yield
-
P/E
-1
Market Cap
5,854,426
OverviewSignalsIdeasNews
Related Instruments
    A
    ARGX
    -30.67
    (-5.16%)
    563.90 USD
    A
    ARWR
    -2.890
    (-13.49%)
    18.540 USD
    A
    AXON
    -5.56
    (-0.92%)
    599.18 USD
    BIIB
    BIIB
    -4.840
    (-2.94%)
    160.000 USD
    MELI
    MELI
    3.01
    (0.16%)
    1,880.74 USD
    R
    RCKT
    -0.810
    (-5.48%)
    13.980 USD
    S
    SAVA
    0.700
    (2.68%)
    26.850 USD
    T
    TTWO
    -3.950
    (-2.18%)
    177.630 USD
    More
News

Title: Hoth Therapeutics

Sector: Healthcare
Industry: Biotechnology
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.